February 24, 2022 07:27 AM EST
FDA+

Cana­da wants to clear the way for more de­cen­tral­ized clin­i­cal tri­als: Will the US fol­low suit?

Zachary Brennan

Senior Editor

The clin­i­cal tri­al ecosys­tem in North Amer­i­ca was up­end­ed quick­ly by Covid-19, cast­ing a gi­ant spot­light on in­ef­fi­cien­cies and the need to make room for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times